Murat Törüner
Ankara University · 135 works · 5,053 citations · h-index 26
Top works
- Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats
- ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
- Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat
- Role of Nitric Oxide
- European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation
- The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease
- Lamivudine prophylaxis for prevention of chemotherapy‐induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies
- Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
- Efficacy and safety of infliximab in patients with autoimmune hepatitis
- Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)
- Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B
- Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease
- Endoscopic Factors in the Diagnosis of Colorectal Dysplasia in Chronic Inflammatory Bowel Disease
- The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method
- NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease
- Barrett's esophagus: Prevalence and its relationship with dyspeptic symptoms
- Antianoikis Effect of Nuclear Factor-κB through Up-regulated Expression of Osteoprotegerin, BCL-2, and IAP-1
- The Characteristics and Clinical Outcome of Drug-induced Liver Injury